Literature DB >> 18646586

Bacterial conjunctivitis: a review for internists.

Ahmad B Tarabishy1, Bennie H Jeng.   

Abstract

Bacterial conjunctivitis is common and occurs in patients of all ages. Typical signs are a red eye and purulent drainage that persists throughout the day. Gonococcal and chlamydial conjunctivitis must be treated with systemic antibiotics. Bacterial conjunctivitis due to most other organisms can be treated empirically with topical antibiotics. Red flags suggesting a complicated case requiring referral to an ophthalmologist include reduced vision, severe eye pain, a hazy-appearing cornea, contact lens use, and poor response to empirical treatment.

Entities:  

Mesh:

Year:  2008        PMID: 18646586     DOI: 10.3949/ccjm.75.7.507

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  24 in total

1.  Shifting trends in in vitro antibiotic susceptibilities for common bacterial conjunctival isolates in the last decade at the New York Eye and Ear Infirmary.

Authors:  Adebukola Adebayo; Jignesh G Parikh; Steven A McCormick; Mahendra K Shah; Remedios S Huerto; Guopei Yu; Tatyana Milman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-06-08       Impact factor: 3.117

Review 2.  Azithromycin 1.5% ophthalmic solution: in purulent bacterial or trachomatous conjunctivitis.

Authors:  Karly P Garnock-Jones
Journal:  Drugs       Date:  2012-02-12       Impact factor: 9.546

3.  Contact lens to measure individual ion concentrations in tears and applications to dry eye disease.

Authors:  Ramachandram Badugu; Bennie H Jeng; E Albert Reece; Joseph R Lakowicz
Journal:  Anal Biochem       Date:  2017-11-26       Impact factor: 3.365

4.  Conjunctivitis: systematic approach to diagnosis and therapy.

Authors:  Onsiri Thanathanee; Terrence P O'Brien
Journal:  Curr Infect Dis Rep       Date:  2011-04       Impact factor: 3.725

Review 5.  Moxifloxacin 0.5% ophthalmic solution: in bacterial conjunctivitis.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2011-01-01       Impact factor: 9.546

Review 6.  Conjunctivitis: a systematic review of diagnosis and treatment.

Authors:  Amir A Azari; Neal P Barney
Journal:  JAMA       Date:  2013-10-23       Impact factor: 56.272

7.  Assessment of Streptococcus pneumoniae capsule in conjunctivitis and keratitis in vivo neuraminidase activity increases in nonencapsulated pneumococci following conjunctival infection.

Authors:  Erin W Norcross; Nathan A Tullos; Sidney D Taylor; Melissa E Sanders; Mary E Marquart
Journal:  Curr Eye Res       Date:  2010-09       Impact factor: 2.424

8.  Besifloxacin: a novel anti-infective for the treatment of bacterial conjunctivitis.

Authors:  Timothy L Comstock; Paul M Karpecki; Timothy W Morris; Jin-Zhong Zhang
Journal:  Clin Ophthalmol       Date:  2010-04-26

Review 9.  Levofloxacin 0.5% ophthalmic solution: a review of its use in the treatment of external ocular infections and in intraocular surgery.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2009-06-18       Impact factor: 9.546

10.  Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.

Authors:  Wolfgang Haas; Chris M Pillar; Gary E Zurenko; Jacqueline C Lee; Lynne S Brunner; Timothy W Morris
Journal:  Antimicrob Agents Chemother       Date:  2009-06-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.